NasdaqCM - Delayed Quote USD
Equillium, Inc. (EQ)
0.4382
-0.0218
(-4.74%)
At close: April 25 at 4:00:00 PM EDT
0.4208
-0.02
(-3.99%)
After hours: April 25 at 4:00:08 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BIOCON SA Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Oct 16, 2018 | 2,316,130 |
| CONNELLY STEPHEN Officer and Director | Sale | Oct 6, 2021 | 993,000 |
| KEYES JASON A Chief Financial Officer | Sale | Jan 23, 2025 | -- |
| ROTHMAN JOEL Officer | Stock Award(Grant) | Dec 8, 2023 | 58,150 |
| TOM PENNY Officer | Sale | Oct 28, 2024 | 6,533 |
| ZEDELMAYER CHRISTINE Chief Operating Officer | Sale | Oct 28, 2024 | 135,246 |
Related Tickers
MTNB Matinas BioPharma Holdings, Inc.
0.6700
+12.60%
DSGN Design Therapeutics, Inc.
3.8800
-8.49%
ANTX AN2 Therapeutics, Inc.
1.2500
-3.10%
ZNTL Zentalis Pharmaceuticals, Inc.
1.4300
-5.30%
ANIX Anixa Biosciences, Inc.
2.7600
+2.22%
AVTX Avalo Therapeutics, Inc.
4.7800
-2.05%
CDTX Cidara Therapeutics, Inc.
21.54
+0.28%
SPRC SciSparc Ltd.
0.2860
-1.11%
COCP Cocrystal Pharma, Inc.
1.7090
+14.70%
SPRB Spruce Biosciences, Inc.
0.1298
-7.22%